HealthEquity Price To Sales vs. Profit Margin
| HQY Stock | USD 102.47 1.10 1.06% |
HealthEquity Price To Sales Ratio |
|
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.46 | 0.6229 |
|
| |||||
| Operating Profit Margin | 0.18 | 0.1282 |
|
|
For HealthEquity profitability analysis, we use financial ratios and fundamental drivers that measure the ability of HealthEquity to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well HealthEquity utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between HealthEquity's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of HealthEquity over time as well as its relative position and ranking within its peers.
HealthEquity |
HealthEquity's Revenue Breakdown by Earning Segment
Check out Risk vs Return Analysis.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of HealthEquity. If investors know HealthEquity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about HealthEquity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 2.333 | Earnings Share 1.2 | Revenue Per Share 12.733 | Quarterly Revenue Growth 0.231 | Return On Assets 0.034 |
The market value of HealthEquity is measured differently than its book value, which is the value of HealthEquity that is recorded on the company's balance sheet. Investors also form their own opinion of HealthEquity's value that differs from its market value or its book value, called intrinsic value, which is HealthEquity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because HealthEquity's market value can be influenced by many factors that don't directly affect HealthEquity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between HealthEquity's value and its price as these two are different measures arrived at by different means. Investors typically determine if HealthEquity is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, HealthEquity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
HealthEquity Profit Margin vs. Price To Sales Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining HealthEquity's current stock value. Our valuation model uses many indicators to compare HealthEquity value to that of its competitors to determine the firm's financial worth. HealthEquity is one of the top stocks in price to sales category among its peers. It also is one of the top stocks in profit margin category among its peers fabricating about 0.01 of Profit Margin per Price To Sales. The ratio of Price To Sales to Profit Margin for HealthEquity is roughly 85.62 . At this time, HealthEquity's Price To Sales Ratio is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the HealthEquity's earnings, one of the primary drivers of an investment's value.HealthEquity Profit Margin vs. Price To Sales
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
HealthEquity |
| = | 8.23 X |
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
HealthEquity |
| = | 0.1 % |
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
HealthEquity Profit Margin Comparison
HealthEquity is currently under evaluation in profit margin category among its peers.
HealthEquity Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in HealthEquity, profitability is also one of the essential criteria for including it into their portfolios because, without profit, HealthEquity will eventually generate negative long term returns. The profitability progress is the general direction of HealthEquity's change in net profit over the period of time. It can combine multiple indicators of HealthEquity, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Operating Income | 128.1 M | 134.5 M | |
| Income Before Tax | 75 M | 78.8 M | |
| Total Other Income Expense Net | -53.1 M | -50.4 M | |
| Net Loss | -23.5 M | -22.4 M | |
| Net Income | 55.7 M | 58.5 M | |
| Income Tax Expense | 19.3 M | 20.3 M | |
| Net Income From Continuing Ops | 55.7 M | 58.5 M | |
| Non Operating Income Net Other | 5.8 M | 6 M | |
| Net Interest Income | -43.3 M | -45.5 M | |
| Interest Income | 12.1 M | 12.7 M | |
| Change To Netincome | 52.6 M | 55.2 M | |
| Net Income Per Share | 0.65 | 0.48 | |
| Income Quality | 4.36 | 3.88 | |
| Net Income Per E B T | 0.74 | 0.73 |
HealthEquity Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on HealthEquity. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of HealthEquity position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the HealthEquity's important profitability drivers and their relationship over time.
Use HealthEquity in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if HealthEquity position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HealthEquity will appreciate offsetting losses from the drop in the long position's value.HealthEquity Pair Trading
HealthEquity Pair Trading Analysis
The ability to find closely correlated positions to HealthEquity could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace HealthEquity when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back HealthEquity - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling HealthEquity to buy it.
The correlation of HealthEquity is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as HealthEquity moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if HealthEquity moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for HealthEquity can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your HealthEquity position
In addition to having HealthEquity in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run SPAC Thematic Idea Now
SPAC
Entities that are involved in raising capital, merging with and acquiring companies, and investing in private equity through leveraged buyouts. The SPAC theme has 25 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize SPAC Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for HealthEquity Stock Analysis
When running HealthEquity's price analysis, check to measure HealthEquity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HealthEquity is operating at the current time. Most of HealthEquity's value examination focuses on studying past and present price action to predict the probability of HealthEquity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HealthEquity's price. Additionally, you may evaluate how the addition of HealthEquity to your portfolios can decrease your overall portfolio volatility.